- 01/05/2022 - 30/04/2025
- Ibrahim Abubakhar (University College of London - UCL)
- Funded by
- European Commission, Horizon 2021-2024
The END-VOC consortium will support the European and global response to the COVID-19 pandemic and Variants of Concern (VOC) through well-characterised cohorts and linked with existing European and international initiatives.
END-VOC consists of 19 partners in Europe (UK, Spain, Italy, Germany, Netherlands, Norway, Italy), South America (Brazil and Peru), Africa (Mozambique, South Africa, Nigeria and 13 ANTICOV African countries), Middle East (Palestine) and Asia (India, Pakistan, Philippines) with a focus on countries affected by VOCs and VOIs.
The project aims to elucidate the global circulation of the current and emerging SARS-CoV-2 VOCs and their characteristics, including transmissibility, pathogenicity and propensity to cause reinfection, to support best control strategies and the development of diagnostics; evaluate the impact of VOCs on the effectiveness of different vaccines and vaccination strategies, and assess the implications of VOCs on the choice of optimal treatment options.
END-VOC will also investigate how VOCs alter long-term post-infection sequelae and where new VOCs emerge within hosts using our clinical cohorts.
The project will inform future preparedness and response by working closely with international and national public health organisations and existing cohort consortia. Specific beyond state-of-the-art components of END-VOC include the use of novel phylogenetic prediction tools and mathematical modelling; generation of powerful cohorts through sentinel surveillance in low and middle-income settings and cohorts of travellers to increase our global reach; use of novel predictive modelling of clinical outcomes by VOC and comorbidity/treatment and evaluation of differences in natural and vaccine immunity by VOC; antiviral screening models within cohorts and artificial intelligence-driven tool for the prediction of long COVID.
Elisabeth Cardis Head of the Radiation Program
Quique Bassat ICREA Research Professor, Head of the Malaria Programme
Gemma Castaño Project Manager
Patricia de Llobet Research technician
Elizabet Diago Associated Researcher
Carlota Dobaño Research Professor
Gonzalo Fanjul Policy Director
Alberto García-Basteiro Associate Research Professor
Clara Marín Policy Coordinator
Lucia Massini Global Development Coordinator
Gemma Moncunill Assistant Research Professor
Jose Muñoz Associate Research Professor
Denise Naniche Scientific Director
Leire Pajín Global Development Director
Paula Petrone Associate Research Professor
Joana Porcel Research Manager
Adelaida Sarukhan Scientific writer
Rafael Vilasanjuan Director of Policy and Global Development
Other projectsSee Past Projects
Combating Bacterial Resistance In Europe
Application to medical devices
Combatting Bacterial Resistance in Europe - Carbapenem Resistance
Prioritising Antimicrobial Resistance: establishing an interdisciplinary International Research Partnership to tackle an evolving global health threat
An interdisciplinary International Research Partnership to tackle an evolving global health threat
Development of new metal-antibiotics against pathogens causing chronic infections in patients with cystic fibrosis.
New metal-antibiotics for patients with cystic fibrosis
Non-invasive ultrasound-based screening for meningitis: Proof-of concept in infants
Improved case detection through TB contact risk stratification by Xpert results and spatial parameters in Mozambique
Evaluation of the effect of weekly high dose rifapentine and isoniazid (3HP) vs periodic 3HP vs 6H for preventing TB among HIV-positive individuals
Search for new target proteins and use of antibacterial or inhibitory peptides against resistance mechanisms in 'Acinetobacter baumannii'
Optimizing provider-initiated HIV testing, linkage, and retention in care in the district of Manhiça, Mozambique
Integrating and decentralizing diabetes and hypertension services in Africa
Searching the hidden: evaluating dengue, chikungunya and Zika autochthonous transmission in the city of Barcelona.
Eficacia de hidroxicloroquina en la prevención de la infección por SARS-CoV-2 y de la gravedad de la enfermedad de COVID-19 durante el embarazo
Pilot Study to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission
Cendea de Cizur
Conèixer la propagació. Entendre la protecció
A breakthrough device for the rapid detection of antimicrobial resistance
Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19
Hepatitis B Virus COMmunity Screening and Vaccination in Africans
Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV
Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.
Close the Gap, Increase Access, Provide Adequate Therapy
Strengthening Epidemiological Surveillance in Benin and Burkina Faso for an Effective Response to COVID-19
Air Pollution in Relation to COVID-19 Morbidity and Mortality: A Large Population-Based Cohort Study in Catalonia
Reconnecting Transmission to Global Tuberculosis Control by Mapping Pathogen Transmission Events to Host Infection Status
Quantifiable stool-based TB PCR to Improve Diagnostics and Treatment Monitoring
“If you do not change direction, you will end up where you are heading”. This famous quote , often attributed to Lao-Tzu, could be...Training 13.04.2022
First Health Emergency Faced by the European Health Emergency Preparedness and Response Authority: War in Ukraine
The European Health Emergency Preparedness and Response Authority ( HERA ) was officially launched earlier this year. HERA forms part of the...Policy & Global Development 10.03.2022
Are Our Cities and Communities Prepared to Face New Crises? What We Have Learned from the Response to the Pandemic
[This article has been written by Carlos Illán , expert in Development and Agenda 2030 and Leire Pajín , Director of Global...Policy & Global Development, Urban Planning, Environment and Health 04.01.2022
Las enfermedades transmitidas por vectores representan un 17% del total de enfermedades infecciosas a escala mundial. Estas enfermedades son...Research, Policy & Global Development 15.09.2017